Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F0RR
|
|||
| Former ID |
DIB008686
|
|||
| Drug Name |
GSK2592984A
|
|||
| Synonyms |
GSK-2340269A; GSK-2340272A; Pandemrix (H1N1); H1N1 pandemic influenzavaccine (AS03 adjuvanted) 1, GlaxoSmithKline; H1N1 pandemic influenza vaccine 1 (AS03 adjuvanted), GSK; Influenza vaccines (intramuscular, influenza virus infection), GlaxoSmithKline
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Approved | [1], [2] | |
| Company |
GlaxoSmithKline plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [1], [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT01196026) Immunogenicity and Safety Study of Fluarix Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix . U.S. National Institutes of Health. | |||
| REF 3 | Anti-influenza agents from Traditional Chinese Medicine. Nat Prod Rep. 2010 Jan;27(12):1758-80. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.